ArticleAdvanced biomedical research2026
Comparison of the 5-Year Incidence of Dyslipidemia in the Obese and Nonobese Adult Population: Results of the Yazd Health Study (YaHS).
Article in Advanced biomedical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Dyslipidemia is a disease and conditions associated with obesity, which is a chronic health problem. The study aimed to determine the 5-year incidence of dyslipidemia in obese and nonobese participants in Central Iran. Materials and Methods: Using multistage cluster sampling, 9964 participants aged 20-70 years in Yazd, Iran, were recruited between 2014 and 2015. Those with dyslipidemia were excluded, and nondyslipidemia individuals were included in the study. After a 5-year follow-up, the obese and nonobese participants were evaluated for incident dyslipidemia. We used logistic regression to estimate the 5-year incidence rates of dyslipidemia. Results: During the study's follow-up, dyslipidemia was diagnosed in 4.4% of participants (n = 355). The increase in the incidence of dyslipidemia in obese women was 86.1% (179 people) more than in obese men, with 32.7% (n = 48). The adjusted odds ratios (ORs) (95% confidence intervals [CIs]) for dyslipidemia in obese men and women were 1.32 (0.90-1.94) and 2.81 (1.78-4.43). The results of the logistic regression analysis showed that obesity was associated with a higher risk of dyslipidemia in the participants after adjusting for confounding factors. However, there was no difference in the findings between those under 60 and those over 60. Conclusions: The cohort study indicated that during a 5-year period, obesity was linked to a higher incidence of dyslipidemia in the adult population. Thus, by combining effective policies with obesity prevention initiatives, it is possible to reduce the incidence of dyslipidemia, cardiovascular illnesses, and the mortality associated with these conditions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.